[go: up one dir, main page]

DK1954264T3 - Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter - Google Patents

Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter

Info

Publication number
DK1954264T3
DK1954264T3 DK06804890T DK06804890T DK1954264T3 DK 1954264 T3 DK1954264 T3 DK 1954264T3 DK 06804890 T DK06804890 T DK 06804890T DK 06804890 T DK06804890 T DK 06804890T DK 1954264 T3 DK1954264 T3 DK 1954264T3
Authority
DK
Denmark
Prior art keywords
formula
intermediates
preparation
ethyl
prg
Prior art date
Application number
DK06804890T
Other languages
Danish (da)
English (en)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of DK1954264T3 publication Critical patent/DK1954264T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
DK06804890T 2005-12-01 2006-11-29 Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter DK1954264T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (1)

Publication Number Publication Date
DK1954264T3 true DK1954264T3 (da) 2010-01-11

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06804890T DK1954264T3 (da) 2005-12-01 2006-11-29 Fremgangsmåde til fremstilling af epoxybutanol-mellemprodukter

Country Status (19)

Country Link
US (2) US7816537B2 (pl)
EP (2) EP2133345A1 (pl)
JP (1) JP5329969B2 (pl)
KR (1) KR101191682B1 (pl)
CN (1) CN101321522B (pl)
AT (1) ATE444747T1 (pl)
AU (2) AU2006319657B2 (pl)
BR (1) BRPI0619120B1 (pl)
CA (2) CA2629092C (pl)
CY (1) CY1110588T1 (pl)
DE (1) DE602006009698D1 (pl)
DK (1) DK1954264T3 (pl)
ES (1) ES2333258T3 (pl)
HR (1) HRP20090675T1 (pl)
PL (1) PL1954264T3 (pl)
PT (1) PT1954264E (pl)
SI (1) SI1954264T1 (pl)
WO (1) WO2007062542A2 (pl)
ZA (1) ZA200804218B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012006180A2 (pt) 2009-09-21 2015-09-08 Gilead Sciences Inc processos e intermediários para a preparação de análogos de 1'-substituido carba-nucleosídeo
SG186830A1 (en) 2010-07-22 2013-02-28 Gilead Sciences Inc Methods and compounds for treating paramyxoviridae virus infections
KR102129150B1 (ko) 2012-08-07 2020-07-02 바실리어 파마슈티카 아게 이사부코나졸 또는 라부코나졸의 제조 방법
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
BR122020020217B1 (pt) 2015-09-16 2021-08-17 Gilead Sciences, Inc Uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por arenaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
EP4331677A3 (en) 2017-03-14 2024-05-29 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
CA3178212A1 (en) 2017-05-01 2018-11-08 Gilead Sciences, Inc. Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
PL3651734T3 (pl) 2017-07-11 2025-03-31 Gilead Sciences, Inc. Kompozycje zawierające inhibitor polimerazy rna i cyklodekstrynę do leczenia infekcji wirusowych
WO2019031240A1 (ja) 2017-08-10 2019-02-14 住友化学株式会社 エポキシアルコール化合物の製造方法
US11660307B2 (en) 2020-01-27 2023-05-30 Gilead Sciences, Inc. Methods for treating SARS CoV-2 infections
TWI785528B (zh) 2020-03-12 2022-12-01 美商基利科學股份有限公司 1’-氰基核苷之製備方法
EP4132651A1 (en) 2020-04-06 2023-02-15 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
TW202532084A (zh) 2020-05-29 2025-08-16 美商基利科學股份有限公司 瑞德西韋之治療方法
WO2021262826A2 (en) 2020-06-24 2021-12-30 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
PT4204421T (pt) 2020-08-27 2024-06-25 Gilead Sciences Inc Compostos e métodos para o tratamento de infeções virais
JP2025508942A (ja) 2022-03-02 2025-04-10 ギリアード サイエンシーズ, インコーポレイテッド ウイルス感染症の治療のための化合物及び方法
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
WO1999045008A1 (en) * 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) * 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
CA2711852C (en) 2011-10-04
HRP20090675T1 (hr) 2010-01-31
ATE444747T1 (de) 2009-10-15
CA2711852A1 (en) 2007-06-07
BRPI0619120A2 (pt) 2011-09-13
AU2010203301A1 (en) 2010-08-12
DE602006009698D1 (de) 2009-11-19
AU2006319657B2 (en) 2010-08-12
JP2009517413A (ja) 2009-04-30
CA2629092C (en) 2012-01-03
US7816537B2 (en) 2010-10-19
JP5329969B2 (ja) 2013-10-30
CY1110588T1 (el) 2015-04-29
ZA200804218B (en) 2009-01-28
KR101191682B1 (ko) 2012-10-16
US20090299073A1 (en) 2009-12-03
EP1954264A2 (en) 2008-08-13
US20110021794A1 (en) 2011-01-27
ES2333258T3 (es) 2010-02-18
CN101321522A (zh) 2008-12-10
WO2007062542A2 (en) 2007-06-07
CA2629092A1 (en) 2007-06-07
EP1954264B1 (en) 2009-10-07
PL1954264T3 (pl) 2010-02-26
SI1954264T1 (sl) 2010-01-29
BRPI0619120B1 (pt) 2023-10-10
KR20080075014A (ko) 2008-08-13
AU2010203301B2 (en) 2012-06-21
AU2006319657A1 (en) 2007-06-07
EP2133345A1 (en) 2009-12-16
WO2007062542A3 (en) 2007-11-01
US8076494B2 (en) 2011-12-13
CN101321522B (zh) 2012-05-30
PT1954264E (pt) 2009-12-23

Similar Documents

Publication Publication Date Title
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
ECSP099091A (es) Profarmaco de compuesto de cinamida
DK1613304T3 (da) DPP-IV-inhibitorer
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
AR057914A1 (es) Compuestos organicos de azufre y su uso
DK1781683T3 (da) Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
EP1795536A4 (en) PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA
DK1673370T3 (da) Krystallingsk form af linezolid
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
IL208290A0 (en) Process for the preparation of 10-deacetyl-bis-7, 10- trichloroacetylbaccatin iii
ATE503746T1 (de) Neue imidazolidinderivate
DK1601653T3 (da) Fremgangsmåde til fremstilling af substituerede nikotinsyreestre
DK1951747T3 (da) Fremgangsmåde og mellemprodukter til syntese af caspofungin
GB0501964D0 (en) Chemical compounds
MY148980A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
ATE365704T1 (de) 1-acetoxy-3-(substituiertes phenyl) propen- verbindungen verwendbar als zwischenmaterial 1
EP2407510A4 (en) VINYL CHLORIDE RESIN COMPOSITION
SE0402734D0 (sv) Antimiicrobial compounds
DE502006005865D1 (de) Herstellung von 1,7` -dimethyl-2` -propyl-2,5` -bi-1h-benzimidazol
NO20053997L (no) Oligosaccharidderivat
DE602006008836D1 (de) Reaktionsprodukt von Resorcin und Methylethylketon